Empty Capsules Market: By Product Type, By Application, By Route of Administration, By End user and Region Forecast 2019 - 2030
Empty Capsules Market size was valued at US$ 2,301 million in 2023, and it is expected to witness a revenue of US$ 3,590 million in 2030, with a significant CAGR of 7.5% from 2024-2030. Empty capsules are made up of gelatin, derived from the animal protein (such as pork skin, fish bones, and animal skin and bones) and plant polysaccharides (HPMC, pullulan, starch etc.). Empty capsules contain two parts namely a lower diameter or body filled with the various drugs and sealed with higher-diameter or cap. Various prescribed and OTC drugs, herbal drugs, and nutritional substances can be dispensed by filling in the empty capsules. Apart from this, empty capsules are also used to fill semi-solid and liquid dosage forms, especially for the drugs which have poor bioavailability, critical stability, poor water solubility, and low melting points etc.
The advantages of the empty capsules are that they are low sensitive to oxygen permeability and have constant capsule dimensions. Global market is in the developed stage with the availability of both gelatin and non-gelatin based capsules. Several local and international players are manufacturing the empty capsules with technological advancements such as enteric coated and extended-release capsules, which release the drug for a long time. The usage of capsules is increased owing to its advantages such as taste and odour masking ability of the drugs and protect the drug from unfavourable atmospheric conditions. Acquisitions and mergers, collaborations, technological advancements, and diversification of business segment around the globe are some strategies followed by the companies to increase their revenue in the market.
Study Period
2024-2030Base Year
2023CAGR
7.5%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the preference for vegetarian based empty capsules by various manufacturers, rise in the adoption of vegetarian empty capsules by the vegan groups, increase in the technological advancements, and attractive capsule design is the key factors expected to propel the empty capsules market growth. Furthermore, rise in consumer demand for capsules over tablets, and various advantages of capsules such as masking of unpleasant taste and odour of the drugs, increase the bioavailability and stability of the drugs expected to fuel the market over the forecast period. However, the rise in prices of raw materials of empty capsules and socio-culture issues regarding the administration of gelatin capsules anticipated restraining the market over the forecast timeframe.
Europe holds a dominant share, which is attributed to technological advancements in the empty capsules, increase in the healthcare expenditure, an increase in the demand for capsule consumption over the tablets is expected to bolster the market in the Europe region.
Asia Pacific is anticipated grow at significant rate owing to increase in the number of pharmaceutical and nutraceutical companies, ease of regulatory approvals in the nutraceutical industries, rise in healthcare expenditure, an increase in the prevalence of various infectious diseases might fuel the growth of the empty capsules market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2,301 million |
|
Market Size in 2030 |
US$ 3,590 million |
|
Market CAGR |
7.5% |
|
By Product Type |
|
|
By Application |
|
|
By Administration |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The empty capsules market size was valued at US$ 2,301 million in 2023 and is projected to grow at a CAGR of 7.5% from 2024 - 2030
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players are ACG Worldwide (India), CapsCanada Corporation (Canada), Suheung Co., Ltd. (Korea), Qualicaps, Inc. (U.S.), Snail Pharma Industry Co. (China), Roxlor LLC (U.S.), Medi-Caps Ltd. (India), Lonza Group AG (Switzerland), Bright Pharma Caps (U.S.)
| 1. Executive Summary |
| 2. Global Empty Capsules Market Introduction |
| 2.1.Global Empty Capsules Market - Taxonomy |
| 2.2.Global Empty Capsules Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Administration |
| 2.2.4. End User |
| 2.2.5.Region |
| 3. Global Empty Capsules Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Empty Capsules Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Empty Capsules Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Gelatin or animal source capsules |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Non-gelatin or plant source capsules |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Empty Capsules Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Antibiotics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Vitamins |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Anti-inflammatory |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Empty Capsules Market By Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Oral |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Inhalation |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Empty Capsules Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Pharmaceutical and Biotechnology companies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Nutraceutical companies |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Others |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Empty Capsules Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Empty Capsules Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Gelatin or animal source capsules |
| 10.1.2.Non-gelatin or plant source capsules |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Antibiotics |
| 10.2.2.Vitamins |
| 10.2.3.Anti-inflammatory |
| 10.2.4.Others |
| 10.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oral |
| 10.3.2.Inhalation |
| 10.3.3.Others |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pharmaceutical and Biotechnology companies |
| 10.4.2.Nutraceutical companies |
| 10.4.3.Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Empty Capsules Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Gelatin or animal source capsules |
| 11.1.2.Non-gelatin or plant source capsules |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Antibiotics |
| 11.2.2.Vitamins |
| 11.2.3.Anti-inflammatory |
| 11.2.4.Others |
| 11.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oral |
| 11.3.2.Inhalation |
| 11.3.3.Others |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pharmaceutical and Biotechnology companies |
| 11.4.2.Nutraceutical companies |
| 11.4.3.Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Empty Capsules Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Gelatin or animal source capsules |
| 12.1.2.Non-gelatin or plant source capsules |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Antibiotics |
| 12.2.2.Vitamins |
| 12.2.3.Anti-inflammatory |
| 12.2.4.Others |
| 12.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oral |
| 12.3.2.Inhalation |
| 12.3.3.Others |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pharmaceutical and Biotechnology companies |
| 12.4.2.Nutraceutical companies |
| 12.4.3.Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Empty Capsules Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Gelatin or animal source capsules |
| 13.1.2.Non-gelatin or plant source capsules |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Antibiotics |
| 13.2.2.Vitamins |
| 13.2.3.Anti-inflammatory |
| 13.2.4.Others |
| 13.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oral |
| 13.3.2.Inhalation |
| 13.3.3.Others |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pharmaceutical and Biotechnology companies |
| 13.4.2.Nutraceutical companies |
| 13.4.3.Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Empty Capsules Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Gelatin or animal source capsules |
| 14.1.2.Non-gelatin or plant source capsules |
| 14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Antibiotics |
| 14.2.2.Vitamins |
| 14.2.3.Anti-inflammatory |
| 14.2.4.Others |
| 14.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Oral |
| 14.3.2.Inhalation |
| 14.3.3.Others |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pharmaceutical and Biotechnology companies |
| 14.4.2.Nutraceutical companies |
| 14.4.3.Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.ACG Worldwide (India) |
| 15.2.2.CapsCanada Corporation (Canada) |
| 15.2.3.Suheung Co., Ltd. (Korea) |
| 15.2.4.Qualicaps, Inc. (U.S) |
| 15.2.5.Snail Pharma Industry Co. (China) |
| 15.2.6.Roxlor LLC (U.S) |
| 15.2.7.Medi-Caps Ltd. (India) |
| 15.2.8.Lonza Group AG (Switzerland) |
| 15.2.9.Bright Pharma Caps (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
